Correlation between Acute Phase Symptoms with Neurological Long Covid Symptoms on COVID-19 Survivors

Authors

  • Ahmad Rizal Ganiem Department of Neurology Faculty of Medicine Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital Bandung
  • Siuliyanty Siuliyanty Department of Neurology Faculty of Medicine Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital Bandung
  • Anam Ong Department of Neurology Faculty of Medicine Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital Bandung
  • Uni Gamayani Department of Neurology Faculty of Medicine Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital Bandung
  • Lisda Amalia Department of Neurology Faculty of Medicine Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital Bandung
  • Yusuf Wibisono Department of Neurology Faculty of Medicine Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital Bandung

DOI:

https://doi.org/10.15850/ijihs.v11n2.3215

Keywords:

Chronic fatigue syndrome, cognitive impairment, Long COVID, poor sleep quality

Abstract

Objective: To investigate prolonged neurological impacts of COVID-19 and establish a connection between initial COVID-19 symptom severity and chronic fatigue syndrome (CFS) development, poor sleep quality (PSQ), and cognitive impairment (CI) in individuals recovered from COVID-19.

Methods:  This cross-sectional study recruited COVID-19 survivors at Dr. Hasan Sadikin General Hospital Bandung, Indonesia, between June and December 2021. All participants gave informed consent and underwent interviews on demography, clinical features, long-COVID questionnaire, and neurological examination. Participants underwent cognitive examination (MOCA-INA), Chalder Fatigue Scale and Pittsburgh Sleep Quality Index (PSQI) to assess CI, CFS, and PSQ variables. Chi-Square analysis was performed to determine the probability of neurological long COVID-19 syndrome manifestations using SPSS 24.0.

Results: Of the 127 participants recruited, 67.7% were women, median (IQR) age of 33 (21-65) years, and time from hospitalization to examination of nine months (1-13). The most common neurological Long COVID symptoms were PSQ (59.8. %), CFS (51.2%), and CI (33.9%). Participants with more than five acute phase COVID-19 symptoms had a higher probability of CFS and CI (OR 2.38 (1, 16-4.9, CI 95%); OR 2.20 (1.01-4.79, CI 95%)) than those with less than five symptoms. The study did not find a significant correlation between sleep quality and number of acute-phase COVID-19 symptoms (OR 1.56 (0.76-3.20, CI 95%)).

Conclusion: Almost two-thirds of the COVID-19 survivors experienced PSQ, more than half had CFS, and almost one-third had CI. The study revealed an increasing likelihood of CFS and CI in COVID-19 survivors as the number of acute COVID-19 symptoms increases.

References

  1. DeKosky ST, Kochanek PM, Valadka AB, Clark RSB, Chou SH, Au AK, et al. Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients. J Neurotrauma. 2021;38(1):1–43. doi:10.1089/neu.2020.7332
  2. WHO. WHO COVID-19. WHO; 2021. Available from: https://covid19.who.int/?gclid=CjwKCAiA9vOABhBfEiw.
  3. Satuan Tugas Penanganan COVID-19. Peta Sebaran COVID-19 [Internet]. 2021. https://covid19.go.id/peta-sebaran-covid19. Available from: Available from: https://covid19.go.id/peta-sebaran-covid19.
  4. Morley JE. Editorial: COVID-19 - The Long Road to Recovery. J Nutr Health Aging. 2020;24(9):917–9. doi:10.1007/s12603-020-1473-6
  5. Rambe AS, Fitri FI. Correlation between the Montreal Cognitive Assessment-Indonesian Version (Moca-INA) and the Mini-Mental State Examination (MMSE) in Elderly. Open Access Maced J Med Sci. 2017;5(7):915–9. doi:10.3889/oamjms.2017.202
  6. Jackson C. The Chalder Fatigue Scale (CFQ 11). Occup Med (Lond). 2015;65(1):86. doi:10.1093/occmed/kqu168
  7. Setyowati A, Chung MH. Validity and reliability of the Indonesian version of the Pittsburgh Sleep Quality Index in adolescents. Int J Nurs Pract. 2021;27(5):e12856. doi:10.1111/ijn.12856
  8. Wang Y, Sibaii F, Lee K, J. Gill M, L. Hatch J. NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. 1. medRxiv. 2021;1(165):1–13.
  9. Del Brutto OH, Rumbea DA, Recalde BY, Mera RM. Cognitive sequelae of long COVID may not be permanent: A prospective study. Eur J Neurol. 2022;29(4):1218–21. doi:10.1111/ene.15215
  10. Liu YH, Wang YR, Wang QH, Chen Y, Chen X, Li Y, et al. Post-infection cognitive impairments in a cohort of elderly patients with COVID-19. Mol Neurodegener. 2021;16(1):1–10.
  11. Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mulè G, et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2022;28(4):611.e9-611.e16. doi:10.1016/j.cmi.2021.11.002
  12. Desdiani D, Sutarto AP, Kharisma AN, Safitri H, Hakim AF, Rusyda SH. Sequelae in COVID-19 patients 3 months after hospital discharge or completion of self-isolation. Health Sci Rep. 2021;4(4):e444. doi:10.1002/hsr2.444
  13. Dennis A, Wamil M, Alberts J, et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11(3):e048391. doi:10.1136/bmjopen-2020-048391
  14. Tamara A, Tahapary DL. Obesity as a predictor for a poor prognosis of COVID-19: A systematic review. Diabetes Metab Syndr. 2020;14(4):655–9. doi:10.1016/j.dsx.2020.05.020
  15. Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, et al. Comorbidity and its Impact on Patients with COVID-19. SN Compr Clin Med. 2020;2(8):1069–76. doi:10.1007/s42399-020-00363-4
  16. Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220–32. doi:10.1016/S0140-6736(20)32656-8
  17. Zapatero DZ, Hanquet G, Heede K Van Den. Epidemiology of long COVID: a pragmatic review of the literature. KCE. 2021;1–16.
  18. Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, et al. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114(9):428–42. doi:10.1177/01410768211032850
  19. National Institute for Health and Care Excellence (NICE) SIGN (SIGN) and RC of GP (RCGP). Covid19-Rapid-Guideline-Managing-the-Longterm-Effects-of-Covid19-Pdf-51035515742. 114 Publ 01032022. 2022;1–106.
  20. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601–15. doi:10.1038/s41591-021-01283-z
  21. Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Prevalence and determinants of fatigue after covid-19 in non-hospitalized subjects: a population-based study. Int J Environ Res Public Health. 2021;18(4):2030. doi:10.3390/ijerph18042030
  22. Goërtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?. ERJ Open Res. 2020;6(4):00542–2020. doi:10.1183/23120541.00542-2020
  23. Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020;15(11):e0240784. doi:10.1371/journal.pone.0240784
  24. Seeßle J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A,, et al. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin Infect Dis. 2022;74(7):1191–8. doi:10.1093/cid/ciab611
  25. Miskowiak KW, Fugledalen L, Jespersen AE, Sattler SM, Podlekareva D, et al. Trajectory of cognitive impairments over 1 year after COVID-19 hospitalisation: Pattern, severity, and functional implications. Eur Neuropsychopharmacol. 2022;59:82–92. doi:10.1016/j.euroneuro.2022.04.004
  26. Fernández-de-Las-Peñas C, Torres-Macho J, Elvira-Martínez CM, Molina-Trigueros LJ, Sebastián-Viana T, Hernández-Barrera V. Obesity is associated with a greater number of long-term post-COVID symptoms and poor sleep quality: A multicentre case-control study. Int J Clin Pract. 2021;75(12):e14917. doi:10.1111/ijcp.14917
  27. Bhaskar S, Sinha A, Banach M, Mittoo S, Weissert R, Kass JS, et al. Cytokine Storm in COVID-19-immunopathological mechanisms, clinical considerations, and therapeutic approaches: The REPROGRAM consortium position paper. Front Immunol. 2020;11:1648. doi:10.3389/fimmu.2020.01648
  28. Vitale JA, Perazzo P, Silingardi M, Biffi M, Banfi G, Negrini F. Is disruption of sleep quality a consequence of severe Covid-19 infection? A case-series examination. Chronobiol Int. 2020;37(7):1110–14. doi:10.1080/07420528.2020.1775241

Downloads

Published

2023-09-30

Issue

Vol. 11 No. 2 (2023)

Section

Articles

License

Authors retain copyright and grant International Journal of Integrated Health Sciences right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to freely share and remix the work with an acknowledgement of the work's authorship and initial publication in International Journal of Integrated Health Sciences.